Aarti Pharmalabs Limited (AARTIPHARM) — Corporate Action | 17 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Record date set for final dividend payment
🔄 What Changed
Dividend amount of ₹2 per share declared
🔮 What's Next
Payment by October 20, 2026
💡 Investor Takeaway
Shareholders receive ₹2 per share if the dividend is approved at the upcoming AGM.

Aarti Pharmalabs announced a final dividend of ₹2 per share (40% yield) for FY 2025-26, with a record date of September 15, 2026 and payment by October 20, 2026, contingent on shareholder approval at the AGM on September 22, 2026.

📄 View Original Announcement (PDF)

About Aarti Pharmalabs Limited (AARTIPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹7,657.91 Cr P/E: 35.9 ROE: 10.7% ROCE: 14.1% Div Yield: 0.41%

View full AARTIPHARM stock details →

📡 Get AI alerts when AARTIPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AARTIPHARM — Free

📊 More AARTIPHARM filings

See all AARTIPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AARTIPHARM files new disclosures

Track AARTIPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AARTIPHARM — Free

Free account · 2 AI queries/day